Effect of Alirocumab on Mortality After Acute Coronary Syndromes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Effect of Alirocumab on Mortality After Acute Coronary Syndromes: An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial
Circulation 2019 May 23;[EPub Ahead of Print], PG Steg, M Szarek, DL Bhatt, VA Bittner, MF Brégeault, AJ Dalby, R Diaz, JM Edelberg, SG Goodman, C Hanotin, RA Harrington, JW Jukema, G Lecorps, KW Mahaffey, A Moryusef, P Ostadal, A Parkhomenko, R Pordy, MT Roe, P Tricoci, R Vogel, HD White, AM Zeiher, GG SchwartzFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.